RAF265 inhibits the growth of advanced human melanoma tumors

  • Su, Y.
  • Kelley, M. C.
  • Splittgerber, R. C.
  • Kantrow, S.
  • Short, S. P.
  • Sobolik-Delmaire, T.
  • Zaja-Milatovic, S.
  • Liu, Y.
  • Vilgelm, A. E.
  • Hawkins, O. E.
  • Dahlman, K. B.
  • Amiri, K. I.
  • Jiang, A.
  • Lu, P.
  • Shyr, Y.
  • Stuart, D. D.
  • Levy, S.
  • Sosman, J. A.
  • Richmond, A.

  • 1 Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA;

    2Division of Surgical Oncology, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA;

    3Pathology Consultants, St. Thomas Hospital, Nashville, TN, USA;

    4Division of Cancer Biostatistics, Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA;

    5Novartis Institutes for Biomedical Research, Emeryville, CA, USA;

    6Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA;

    7Division of Hematology/Oncology, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, USA;

    8Department of Veterans Affairs, Vanderbilt University Medical Center, Nashville, TN, USA

Pigment Cell & Melanoma Research 24(5):p 1001-1002, October 2011.
Copyright © 2011 Blackwell Publishing Ltd.
View full text|Download PDF